Neuberger Berman Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Neuberger Berman Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,200	Closed	-$598K	–	1618
2019 Q3	$598K	Buy	+5,200	New	+$789K	﹤0.01%	1245
2017 Q1	–	Sell	-7,314	Closed	-$817K	–	1664
2016 Q4	$817K	Buy	+7,314	New	+$880K	﹤0.01%	1186
2014 Q1	–	Sell	-23,000	Closed	-$955K	–	1684
2013 Q4	$955K	Buy	+23,000	New	+$728K	﹤0.01%	1222

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MGIM

M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group's GWPH Position: Q4 2019 in Review

Neuberger Berman Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2019, closing a stake of 5,200 shares — an estimated $598K sold.

Neuberger Berman Group first reported a position in GWPH in Q4 2013 and held it in 3 quarters. The position peaked at $955K in Q4 2013. 318 funds tracked by Wall St. Rank hold GWPH as of Q4 2019.

Neuberger Berman Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2019 after selling out during the quarter.
Neuberger Berman Group sold 5,200 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2019, an estimated $598K.
Neuberger Berman Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 3 quarters.
Neuberger Berman Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $955K in Q4 2013.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2019.

Based on Neuberger Berman Group's 13F filing for Q4 2019, filed 12 Feb 2020.